Inhalator
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front elevational view of an inhalator in the open position, showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a perspective view from the bottom front thereof;
FIG. 6 is a front elevational view of the inhalator shown in FIGS. 1-5 in the closed position;
FIG. 7 is a bottom plan view thereof;
FIG. 8 is a rear elevational view thereof;
FIG. 9 is a left side elevational view thereof; and,
FIG. 10 is a perspective view thereof from the bottom front.
Referenced Cited
Patent History
Patent number: D342994
Type: Grant
Filed: Jan 14, 1992
Date of Patent: Jan 4, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventors: Paul K. Rand (Ware), David J. Hearne (Ware)
Primary Examiner: Stella Reid
Law Firm: Darby & Darby
Application Number: 7/821,555
Type: Grant
Filed: Jan 14, 1992
Date of Patent: Jan 4, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventors: Paul K. Rand (Ware), David J. Hearne (Ware)
Primary Examiner: Stella Reid
Law Firm: Darby & Darby
Application Number: 7/821,555
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)